Selected research
Industry Research
Lamivudine Drugs Industry Research Report 2026
Market perspective
The global Lamivudine Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lamivudine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lamivudine Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lamivudine Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lamivudine Drugs include Zhongfu Pharmaceutical, Shanghai Desano Pharmaceutical, Shandong Loncom Pharmaceutical, Qianjin Pharmaceutical, Jisikai Suzhou Pharmaceutical, Fujian Cosunter pharmaceutical, Beijing Foyou Pharmaceutical, Anhui Biochem and ViiV Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lamivudine Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lamivudine Drugs Market by Company
Zhongfu Pharmaceutical
Shanghai Desano Pharmaceutical
Shandong Loncom Pharmaceutical
Qianjin Pharmaceutical
Jisikai Suzhou Pharmaceutical
Fujian Cosunter pharmaceutical
Beijing Foyou Pharmaceutical
Anhui Biochem
ViiV Healthcare
Strides Pharma
Mylan Pharmaceuticals
Mylan
Merck
Macleods Pharmaceuticals
Lupin
Cipla
Aurobindo Pharma
Apotex
Lamivudine Drugs Segment by Type
Single Drug
Combination Preparation
Lamivudine Drugs Segment by Application
Hospital and Clinic
Pharmacy
Other
Lamivudine Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lamivudine Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lamivudine Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lamivudine Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lamivudine Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lamivudine Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lamivudine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Drug
- Combination Preparation
Applications
- Hospital and Clinic
- Pharmacy
- Other
Companies covered
- Zhongfu Pharmaceutical
- Shanghai Desano Pharmaceutical
- Shandong Loncom Pharmaceutical
- Qianjin Pharmaceutical
- Jisikai Suzhou Pharmaceutical
- Fujian Cosunter pharmaceutical
- Beijing Foyou Pharmaceutical
- Anhui Biochem
- ViiV Healthcare
- Strides Pharma
- Mylan Pharmaceuticals
- Mylan
- Merck
- Macleods Pharmaceuticals
- Lupin
- Cipla
- Aurobindo Pharma
- Apotex
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lamivudine Drugs Market Size (2021-2032)
- 2.2.2 Global Lamivudine Drugs Sales (2021-2032)
- 2.2.3 Global Lamivudine Drugs Market Average Price (2021-2032)
- 2.3 Lamivudine Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single Drug
- 2.3.3 Combination Preparation
- 2.4 Lamivudine Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinic
- 2.4.3 Pharmacy
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lamivudine Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lamivudine Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lamivudine Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Lamivudine Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Lamivudine Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lamivudine Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lamivudine Drugs, Product Type & Application
- 3.8 Global Manufacturers of Lamivudine Drugs, Established Date
- 3.9 Global Lamivudine Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhongfu Pharmaceutical
- 4.1.1 Zhongfu Pharmaceutical Company Information
- 4.1.2 Zhongfu Pharmaceutical Business Overview
- 4.1.3 Zhongfu Pharmaceutical Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhongfu Pharmaceutical Lamivudine Drugs Product Portfolio
- 4.1.5 Zhongfu Pharmaceutical Recent Developments
- 4.2 Shanghai Desano Pharmaceutical
- 4.2.1 Shanghai Desano Pharmaceutical Company Information
- 4.2.2 Shanghai Desano Pharmaceutical Business Overview
- 4.2.3 Shanghai Desano Pharmaceutical Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Desano Pharmaceutical Lamivudine Drugs Product Portfolio
- 4.2.5 Shanghai Desano Pharmaceutical Recent Developments
- 4.3 Shandong Loncom Pharmaceutical
- 4.3.1 Shandong Loncom Pharmaceutical Company Information
- 4.3.2 Shandong Loncom Pharmaceutical Business Overview
- 4.3.3 Shandong Loncom Pharmaceutical Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Loncom Pharmaceutical Lamivudine Drugs Product Portfolio
- 4.3.5 Shandong Loncom Pharmaceutical Recent Developments
- 4.4 Qianjin Pharmaceutical
- 4.4.1 Qianjin Pharmaceutical Company Information
- 4.4.2 Qianjin Pharmaceutical Business Overview
- 4.4.3 Qianjin Pharmaceutical Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Qianjin Pharmaceutical Lamivudine Drugs Product Portfolio
- 4.4.5 Qianjin Pharmaceutical Recent Developments
- 4.5 Jisikai Suzhou Pharmaceutical
- 4.5.1 Jisikai Suzhou Pharmaceutical Company Information
- 4.5.2 Jisikai Suzhou Pharmaceutical Business Overview
- 4.5.3 Jisikai Suzhou Pharmaceutical Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jisikai Suzhou Pharmaceutical Lamivudine Drugs Product Portfolio
- 4.5.5 Jisikai Suzhou Pharmaceutical Recent Developments
- 4.6 Fujian Cosunter pharmaceutical
- 4.6.1 Fujian Cosunter pharmaceutical Company Information
- 4.6.2 Fujian Cosunter pharmaceutical Business Overview
- 4.6.3 Fujian Cosunter pharmaceutical Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fujian Cosunter pharmaceutical Lamivudine Drugs Product Portfolio
- 4.6.5 Fujian Cosunter pharmaceutical Recent Developments
- 4.7 Beijing Foyou Pharmaceutical
- 4.7.1 Beijing Foyou Pharmaceutical Company Information
- 4.7.2 Beijing Foyou Pharmaceutical Business Overview
- 4.7.3 Beijing Foyou Pharmaceutical Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Beijing Foyou Pharmaceutical Lamivudine Drugs Product Portfolio
- 4.7.5 Beijing Foyou Pharmaceutical Recent Developments
- 4.8 Anhui Biochem
- 4.8.1 Anhui Biochem Company Information
- 4.8.2 Anhui Biochem Business Overview
- 4.8.3 Anhui Biochem Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Anhui Biochem Lamivudine Drugs Product Portfolio
- 4.8.5 Anhui Biochem Recent Developments
- 4.9 ViiV Healthcare
- 4.9.1 ViiV Healthcare Company Information
- 4.9.2 ViiV Healthcare Business Overview
- 4.9.3 ViiV Healthcare Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ViiV Healthcare Lamivudine Drugs Product Portfolio
- 4.9.5 ViiV Healthcare Recent Developments
- 4.10 Strides Pharma
- 4.10.1 Strides Pharma Company Information
- 4.10.2 Strides Pharma Business Overview
- 4.10.3 Strides Pharma Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Strides Pharma Lamivudine Drugs Product Portfolio
- 4.10.5 Strides Pharma Recent Developments
- 4.11 Mylan Pharmaceuticals
- 4.11.1 Mylan Pharmaceuticals Company Information
- 4.11.2 Mylan Pharmaceuticals Business Overview
- 4.11.3 Mylan Pharmaceuticals Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Mylan Pharmaceuticals Lamivudine Drugs Product Portfolio
- 4.11.5 Mylan Pharmaceuticals Recent Developments
- 4.12 Mylan
- 4.12.1 Mylan Company Information
- 4.12.2 Mylan Business Overview
- 4.12.3 Mylan Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Mylan Lamivudine Drugs Product Portfolio
- 4.12.5 Mylan Recent Developments
- 4.13 Merck
- 4.13.1 Merck Company Information
- 4.13.2 Merck Business Overview
- 4.13.3 Merck Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Merck Lamivudine Drugs Product Portfolio
- 4.13.5 Merck Recent Developments
- 4.14 Macleods Pharmaceuticals
- 4.14.1 Macleods Pharmaceuticals Company Information
- 4.14.2 Macleods Pharmaceuticals Business Overview
- 4.14.3 Macleods Pharmaceuticals Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Macleods Pharmaceuticals Lamivudine Drugs Product Portfolio
- 4.14.5 Macleods Pharmaceuticals Recent Developments
- 4.15 Lupin
- 4.15.1 Lupin Company Information
- 4.15.2 Lupin Business Overview
- 4.15.3 Lupin Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Lupin Lamivudine Drugs Product Portfolio
- 4.15.5 Lupin Recent Developments
- 4.16 Cipla
- 4.16.1 Cipla Company Information
- 4.16.2 Cipla Business Overview
- 4.16.3 Cipla Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Cipla Lamivudine Drugs Product Portfolio
- 4.16.5 Cipla Recent Developments
- 4.17 Aurobindo Pharma
- 4.17.1 Aurobindo Pharma Company Information
- 4.17.2 Aurobindo Pharma Business Overview
- 4.17.3 Aurobindo Pharma Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Aurobindo Pharma Lamivudine Drugs Product Portfolio
- 4.17.5 Aurobindo Pharma Recent Developments
- 4.18 Apotex
- 4.18.1 Apotex Company Information
- 4.18.2 Apotex Business Overview
- 4.18.3 Apotex Lamivudine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Apotex Lamivudine Drugs Product Portfolio
- 4.18.5 Apotex Recent Developments
5 Global Lamivudine Drugs Market Scenario by Region
- 5.1 Global Lamivudine Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lamivudine Drugs Sales by Region: 2021-2032
- 5.2.1 Global Lamivudine Drugs Sales by Region: 2021-2026
- 5.2.2 Global Lamivudine Drugs Sales by Region: 2027-2032
- 5.3 Global Lamivudine Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Lamivudine Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Lamivudine Drugs Revenue by Region: 2027-2032
- 5.4 North America Lamivudine Drugs Market Facts & Figures by Country
- 5.4.1 North America Lamivudine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lamivudine Drugs Sales by Country (2021-2032)
- 5.4.3 North America Lamivudine Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lamivudine Drugs Market Facts & Figures by Country
- 5.5.1 Europe Lamivudine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lamivudine Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Lamivudine Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lamivudine Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lamivudine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lamivudine Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lamivudine Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lamivudine Drugs Market Facts & Figures by Country
- 5.7.1 South America Lamivudine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lamivudine Drugs Sales by Country (2021-2032)
- 5.7.3 South America Lamivudine Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Lamivudine Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lamivudine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lamivudine Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lamivudine Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Lamivudine Drugs Sales by Type (2021-2032)
- 6.1.1 Global Lamivudine Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lamivudine Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Lamivudine Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Lamivudine Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lamivudine Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Lamivudine Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lamivudine Drugs Sales by Application (2021-2032)
- 7.1.1 Global Lamivudine Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lamivudine Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Lamivudine Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Lamivudine Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lamivudine Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Lamivudine Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lamivudine Drugs Value Chain Analysis
- 8.1.1 Lamivudine Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lamivudine Drugs Production Mode & Process
- 8.2 Lamivudine Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lamivudine Drugs Distributors
- 8.2.3 Lamivudine Drugs Customers
9 Global Lamivudine Drugs Analyzing Market Dynamics
- 9.1 Lamivudine Drugs Industry Trends
- 9.2 Lamivudine Drugs Industry Drivers
- 9.3 Lamivudine Drugs Industry Opportunities and Challenges
- 9.4 Lamivudine Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst